Determination of apical membrane polarity in mammary epithelial cell cultures: the role of cell-cell, cell-substratum, and membrane-cytoskeleton interactions.
The membrane glycoprotein, PAS-O, is a major differentiation antigen on mammary epithelial cells and is located exclusively in the apical domain of the plasma membrane. We have used 734B cultured human mammary carcinoma cells as a model system to study the role of tight junctions, cell-substratum contacts, and submembraneous cytoskeletal elements in restricting PAS-O to the apical membrane. Immunofluorescence and immunoelectronmicroscopy experiments demonstrated that while tight junctions demarcate PAS-O distribution in confluent cultures, apical polarity could be established at low culture densities when cells could not form tight junctions with neighboring cells. In such cultures the boundary between apical and basal domains was observed at the point of cell contact with the substratum. Immunocytochemical analysis of these cell-substratum contacts revealed the absence of a characteristic basement membrane containing laminin, collagen (IV), and heparan sulfate proteoglycan. However, serum-derived vitronectin was associated with the basal cell surface and the cells were shown to express the vitronectin receptor on their basolateral membranes. Additionally, treatment of cultures with antibodies against the vitronectin receptor caused cell detachment. We suggest, then, that interactions between vitronectin and its receptor, are responsible for establishment of membrane domains in the absence of tight junctions. The role of cytoskeletal elements in restricting PAS-O distribution was examined by treating cultures with cytochalasin D, colchicine, or acrylamide. Cytochalasin D led to a redistribution of PAS-O while colchicine and acrylamide did not. We hypothesize that PAS-O is restricted to the apical membrane by interactions with a microfilament network and that the cytoskeletal organization is dependent upon cell-cell and cell-substratum interactions.
Cell and Molecular Biology Division, Lawrence Berkeley Laboratory, University of California, Berkeley 94720.
G
G
Parry
J C
JC
Beck
L
L
Moss
J
J
Bartley
G K
GK
Ojakian
D008841:Actin Cytoskeleton / Q000502:physiology; D000943:Antigens, Differentiation / Q000032:analysis*; D001485:Basement Membrane / Q000032:analysis / Q000378:metabolism; D001943:Breast Neoplasms / Q000032:analysis / Q000378:metabolism / Q000648:ultrastructure*; D002450:Cell Communication; D002452:Cell Count; D002462:Cell Membrane / Q000032:analysis / Q000502:physiology*; D003599:Cytoskeleton / Q000502:physiology*; D006023:Glycoproteins / Q000378:metabolism; D006801:Humans; D008562:Membrane Glycoproteins / Q000032:analysis*; D008870:Microtubules / Q000502:physiology; D008871:Microvilli / Q000032:analysis; D011971:Receptors, Immunologic / Q000378:metabolism; D019030:Receptors, Vitronectin; D014407:Tumor Cells, Cultured; D019096:Vitronectin
D000943:Antigens, Differentiation; D006023:Glycoproteins; D008562:Membrane Glycoproteins; D011971:Receptors, Immunologic; D019030:Receptors, Vitronectin; D019096:Vitronectin